Pencor

Pencor

doxazosin

Manufacturer:

Unison

Distributor:

Medispec
Concise Prescribing Info
Contents
Doxazosin mesylate
Indications/Uses
HTN & benign prostatic hyperplasia (BPH).
Dosage/Direction for Use
HTN Initially 1 mg, may be increased if necessary. Max: 16 mg. BPH Initially 1 mg once daily. Recommended dose: 2-4 mg. Max: 8 mg.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to quinolones.
Special Precautions
Postural hypotension/syncope; use w/ PDE-5 inhibitors; impaired liver function. Pregnancy & lactation.
Adverse Reactions
Dizziness, vertigo, arrythmias, dyspnea, orthostatic hypotension, priapism, headache, unusual tiredness, nausea & nervousness.
Drug Interactions
PDE-5 inhibitors.
ATC Classification
C02CA04 - doxazosin ; Belongs to the class of alpha-adrenoreceptor antagonists, peripherally-acting antiadrenergic agents. Used in the treatment of hypertension.
Presentation/Packing
Form
Pencor tab 4 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in